M2S Inc., an industry leader in endovascular treatment planning and patient registries, announced today that the company has reached a new milestone, having processed over 150,000 radiographic scans for evaluation and surveillance of aortic aneurysms. With each scan received, M2S evaluates approximately 1,000 images, pushing M2S' total images received and processed to over 150 million.

(PRWEB) November 18, 2008 -- M2S Inc., an industry leader in endovascular treatment planning and patient registries (http://m2s.com/content/endovascular-imaging), announced today that the company has reached a new milestone, having processed over 150,000 radiographic scans for evaluation and surveillance of aortic aneurysms. With each scan received, M2S evaluates approximately 1,000 images, pushing M2S' total images received and processed to over 150 million.

From each scan, M2S provides 3D reconstruction, measurement and patient data registry services (http://m2s.com/content/data-registries) to physicians across the country, providing more accuracy and efficiency for endovascular aortic aneurysm pre-operative planning and post-operative surveillance. The pre- and post-operative analyses are posted to M2S' PEMS® website, providing physicians 24/7 access to their patient data and images. Utilizing the Preview® medical treatment planning software (http://m2s.com/content/preview-treatment-planning-software) from M2S, physicians can also interactively view the 3D model, as well as virtually implant stent grafts onto the 3D model to further optimize the visualization of treatment.

M2S provides image and data management services (http://www.m2s.com/) and patient registries for endovascular treatment planning and clinical trials. Their services are designed to improve health care and reduce the time and cost of clinical trials. For the past 10 years, M2S has worked with many of the world's leading academic centers, pharmaceutical companies, and medical device manufacturers, managing under protocol, millions of images from around the globe. For more information, visit www.M2S.com.

###

Simillar Articles

M2S, Inc. Acquires DXA Resource Group; Expands Core Capabilities in Clinical Trial Image Management

M2S Inc., a global provider of image management services for biopharmaceutical and medical device clinical trials, announced today that the company has acquired DXA Resource Group (DRG) of...

M2S, Inc. releases Preview® Treatment Planning Software, Version 2.10.0

M2S Inc., an industry leader in medical image management and analysis, has released version 2.10.0 of its Preview treatment planning software. M2S's Preview 3D modeling and reconstruction...

Medical Imaging Services Leader M2S Inc Develops New Auto-blinding Technology for Clinical Trials

M2S Inc., an industry leader in medical image management and analysis, has released new auto blinding technology for the DICOM Armorcar® (DAC®). M2S's DAC image transfer technology...

OpenClinica 2.2 Provides Enhanced Features for Popular Open Source Electronic Data Capture Software

Akaza Research releases OpenClinica 2.2, a new version of the popular clinical research software designed for electronic data capture and clinical data management.

Medical Imaging Management Leader M2S Names Ciaran Cooper General Manager of Clinical Trials...

M2S Inc., an industry leader in medical image management and analysis, announced today that it has named Ciaran Cooper its new General Manager of Clinical Trials Services. Cooper was previously...

Home